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Evaluation of a service intervention to
improve awareness and uptake of bowel
cancer screening in ethnically-diverse areas
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Background: Uptake of bowel cancer screening is lowest in London, in populations of lower socio-economic status, and in
particular ethnic or religious groups.
Methods: We report on the evaluation of two interventions to improve uptake in an area including populations of low socio-
economic status and considerable ethnic diversity. The interventions were face-to-face health promotion on bowel cancer
screening at invitees’ general practice and health promotion delivered by telephone only. Nine large general practices in East
London were chosen at random to offer face-to-face health promotion, and nine other large practices to offer telephone health
promotion, with 24 practices of similar size as comparators. Data at practice level were analysed by Mann–Whitney–Wilcoxon tests
and grouped-logistic regression.
Results: There were 2034 invitees in the telephone intervention practices, 1852 in the face-to-face intervention practices and 5227
in the comparison practices. Median gFOBt kit uptake in the target population (aged 59–70) was 46.7% in the telephone practices,
43.8% in the face-to-face practices and 39.1% in the comparison practices. Significant improvements in the odds of uptake were
observed following telephone intervention in both males (OR¼ 1.39, 95% CI¼ 1.20–1.61, Po0.001) and females (OR¼ 1.49, 95%
CI¼ 1.29–1.73, Po0.001), while the face-to-face intervention mainly impacted uptake in males (OR¼ 1.23, 95% CI¼ 1.10–1.36),
Po0.001) but did not lead to a significant increase in females (OR¼ 1.12, 95% CI¼ 0.96–1.29, P¼ 0.2).
Conclusions: Personally delivered health promotion improved uptake of bowel cancer screening in areas of low socio-economic
status and high ethnic diversity. The intervention by telephone appears to be the most effective method.
Colorectal cancer is the fourth most common cancer in the UK and
the second most common cause of cancer death after lung cancer;
in 2010, 40 695 new cases of colorectal cancer and 15 708 deaths
were recorded (Cancer Research UK, 2013). Increasing age is a risk
factor with incidence rising as the population ages. The disease
progresses slowly; a benign growth (polyp) becomes cancerous
*Correspondence: Professor SW Duffy; E-mail: s.w.duffy@qmul.ac.uk
Received 29 January 2014; revised 8 May 2014; accepted 9 June 2014; published online 1 July 2014
& 2014 Cancer Research UK. All rights reserved 0007 – 0920/14
FULL PAPER
Keywords: bowel cancer; screening; faecal blood test (gFOBt); London; ethnicity
British Journal of Cancer (2014) 111, 1440–1447 | doi: 10.1038/bjc.2014.363
1440 www.bjcancer.com |DOI:10.1038/bjc.2014.363
over a period of up to 10 years. Despite slow development of the
disease, 25% of patients first present as emergencies after
experiencing mild symptoms for weeks or months. More than
half of patients are not diagnosed until the disease has spread to
lymph nodes or elsewhere and late diagnosis is a key factor in poor
survival from the disease. Fewer than 50% of patients with lymph
node involvement and only 7% of patients with metastatic spread
are still alive 5 years after diagnosis compared with 93% of patients
with early disease (Dukes Stage A) (National Cancer Intelligence
Network, 2013).
Bowel cancer screening aims both to prevent colorectal cancer
occurrence by identifying and removing polyps, and to increase
survival by diagnosing bowel cancer early, ideally at a pre-
symptomatic stage. The English NHS Bowel Cancer Screening
Programme (NHS BCSP) offers guaiac faecal occult blood testing
(gFOBt) every 2 years for men and women aged 60–69 (Morris
et al, 2012a). Uptake of screening is defined as the percentage of
invited subjects who return an adequately completed gFOBt kit
within 26 weeks of their invitation (BCSS system). The national
target for uptake in the NHS BCSP is 60%. In the prevalent
round of the NHS BCSP, overall participation rates were shown
to be 49.6% in men and 54.4% in women while uptake was lowest
in the London hub (40%) and in the most deprived areas of
London – 33% and 39% in the 4th and 5th index of multiple
deprivation (IMD) quintiles, respectively (Logan et al, 2012). This
is an example of ‘intervention-generated inequality’, the idea that
‘downstream’ preventive interventions can increase health inequal-
ities by disproportionately benefiting more advantaged groups
(Lorenc et al, 2013). The three inner north east London boroughs
(and former Primary Care Trust areas) of City & Hackney,
Newham and Tower Hamlets are characterised by high levels of
deprivation and ethnic diversity (Office for National Statistics,
2001). Tower Hamlets and Newham have among the highest
proportion of residents in England living in households where
English is not spoken.
Survival rates from cancer (including colorectal cancer) in all
three boroughs are lower than England averages and are likely to
be linked to late diagnosis of cancer (Department of Health, 2011).
Recommendation by a trusted health professional such as a GP
has been found to be significantly associated with increased gFOBt
kit uptake within the national screening programme in the south of
England (Hewitson et al, 2011). Recently, an intervention in Tower
Hamlets involving the use of telephone calls by trained bi-lingual
advocates calling on behalf of GPs to endorse screening
contributed to significant increases in the uptake of breast
screening and led to the introduction of a new service specification
(Eilbert et al, 2009).
This project was set up to assess an intervention aimed at
increasing awareness and uptake of bowel cancer screening among
subjects in the London boroughs of City & Hackney, Newham and
Tower Hamlets, to assist progress towards the national screening
target of 60%. The methodology was based on a smaller pilot
project run in 2011 (Massat et al, 2014) using targeted GP
endorsement through letters, and health promotion provided by
health advocates in the invitee’s first language over the telephone,
or during group sessions. Here, we report on the results obtained
for the different targeted age groups.
MATERIALS AND METHODS
Target population. The intervention planned to target up to 5000
subjects invited to participate in bowel cancer screening between
January and December 2012. Delays in obtaining practice
agreements and ITT lists meant that analysis only covers the
period from April to December 2012, with 3886 subjects rather
than 5000. The intervention took place from April to December
2012 and was targeted at the following groups of subjects registered
with the GP practices included in the intervention:
 Target group 1: subjects approaching the age of 60 years who
were due to be invited to participate in the bowel cancer
screening for the first time;
 Target group 2: subjects aged 61 to 69 due for second and
subsequent invitations (recall) whose records showed that they
had not responded to their last gFOBt invitation.
The intervention aimed to exclude subjects whose records
showed that they had a diagnosis of colorectal cancer, palliative
care needs or had opted out of the programme.
Recruitment and participants. Six GP practices in each of the
three boroughs were selected as follows. Lists of all GP practices in
City & Hackney, Newham and Tower Hamlets were compiled in
decreasing order of practice population size. Three sets of
randomised numbers were generated and applied to the GP lists,
with the aim of recruiting six practices in each borough. Practices
identified were contacted in the order of numbers generated and
offered the opportunity to participate in the project. If a practice
declined, the practice which had been assigned to the following
number was approached until six practices in each borough had
been recruited. In each borough, three of the practices that had
agreed to participate were randomly assigned to offer HP over
the telephone (Intervention A) and three practices to offer HP
during monthly face-to-face sessions held at the GP practice
(Intervention B). Practices that were not selected at random for the
intervention or chose not to participate continued to be offered the
usual level of service from the NHS BCSP and from ongoing local
screening and health promotion services.
As the intervention practices were chosen randomly from the
larger practices in the lists, we similarly took as comparison
practices the remaining practices from within the three
boroughs which were also above the median size of the practices
(N¼ 24, 5 in City & Hackney, 10 in Newham and 9 in Tower
Hamlets).
Intervention. A community organisation with experience of
telephone outreach to increase uptake of cancer screening in East
London was commissioned to deliver the intervention on behalf of
the 18 intervention practices. Trained bi-lingual advocates worked
from GP premises with practice staff to carry out the intervention
and provide monitoring data.
Information about all subjects aged 60–69 years, and due to be
invited, was provided monthly by the NHS BCSP as ‘intention-to-
treat’ (ITT) lists to each practice in the intervention set, in line with
data sharing agreements in place. Practices were asked to review
lists and to exclude subjects for whom GP endorsement to
participate in bowel cancer screening would be considered
inappropriate (patient had a diagnosis of colorectal cancer, needed
palliative care or had opted out of the programme).
Intervention A (‘HP over the telephone’). The Community
organisation sent a letter of endorsement on practice-headed
paper, along with a localised version of the NHS BCSP leaflet to
subjects in target groups, 2 weeks after their ‘screening due date’
(that is, as recorded on the ITT list). The letter gave brief
information about the study and offered a telephone call to provide
additional information about the screening test. Using telephone
numbers recorded in GP registers, trained bi-lingual advocates
telephoned subjects 1 week after sending letters, making up to
three attempts to contact each person. Callers offered information
about bowel cancer screening and answered subjects’ questions
using a standardised script. Targeted subjects were offered the
opportunity to opt out at any stage of the intervention.
Uptake of bowel cancer screening BRITISH JOURNAL OF CANCER
www.bjcancer.com |DOI:10.1038/bjc.2014.363 1441
Intervention B (‘HP at face-to-face session’). A letter of endorse-
ment and leaflet as above were sent to subjects in target groups. In
this case, the letter also invited subjects to attend a group health
information session at the GP practice premises. One week later,
advocates telephoned subjects to remind them about the forth-
coming session and answered their questions. Alternative session
dates were provided if appropriate. On the day before each session,
a reminder telephone call was made to those who had agreed to
attend. Sessions were held monthly by trained advocates using a
standardised format. Attendees were offered additional pictorial
and multi-lingual guides to the test procedure and three pairs of
disposable non-latex gloves. Targeted subjects were offered the
opportunity to opt out at any stage of the intervention.
In both interventions, advocates were able to contact the NHS
BCSP on behalf of the subjects invited to request replacement kits
if these had not been received, had been discarded or had been
spoiled. They also asked the subjects if they were willing to
participate in a follow-up telephone interview 3 months after their
screening invitation.
Uptake data. GP practice-level aggregate data on kit completion
(number of invited and of gFOBt screened patients per practice)
was provided by the NHS BCSP for the 18 intervention and 24
comparison practices in the three inner north east London
boroughs for the second, third and fourth quarters of 2012 (April
to December 2012). Results were requested for subjects aged 59–70
years, for the following populations:
 Population aged 59–60 years who received a first invitation:
‘Invited prevalent 59–60’;
 Population aged 61–70 years who received a second or
subsequent invitation and who had never responded to ANY
previous invitations: ‘Invited prevalent 61–70’;
 Population aged 61–70 years who received a second or
subsequent invitation and who had responded to at least one
previous invitation: ‘Invited incident 61–70’;
 Population aged 59–70 years who received a first or subsequent
invitation (above groups combined): ‘All invited 59–70’.
For each population group, data was available for males and
females separately.
Statistical analysis. The uptake rate for each practice was
calculated as the ratio of screened to invited patients (both males
and females), and the median uptake for each borough was derived
as a summary measure to avoid making any strong distributional
assumption for the rates.
Difference in median uptake rates between intervention and
comparison practices was assessed using non-parametric
Mann–Whitney–Wilcoxon (MWW) testing with general practice
as the unit of analysis. A grouped-logistic regression model (Hilbe
and Robinson, 2013) was also fitted to the aggregate participation
data obtained for the aforementioned populations. The effect of the
intervention type (none, HP over the telephone, HP at face-to-face
session), gender and borough and any possible interactions were
investigated. Interaction terms which were not significant, as
assessed using a likelihood ratio test, were dropped from the
model. Intervention by gender was kept in the final model as it was
felt to be of potential interest and achieved significance at the 10%
level for some of the groups investigated. The final model therefore
included all main effects, a gender by intervention group
interaction, and was also adjusted for practice population size.
Results were presented on the odds ratio scale as they are
independent of the level at which the covariate is held constant.
Sensitivity analyses were performed where the same analyses
were repeated after excluding the 12 GP practices involved in the
pilot study run during 2011 which targeted the population aged 60
at the time (Massat et al, 2014). Three of the 12 GP practices which
offered a similar HP intervention in the 2011 pilot study were
included in the intervention set in the current project; four were
included in the comparison set.
All statistical analyses were performed in R version 2.13.0 (The
R Foundation for Statistical Computing, http://www.r-project.org/
foundation).
RESULTS
Table 1 shows an overview of the target population, that is, all
subjects invited to participate in bowel cancer screening during the
second to fourth quarter of 2012 (‘All invited 59–70’). A total of
3886 subjects (49.3% male, 50.7% female) aged between 59 years
and 6 months and 70 years were sent a GP-endorsed letter offering
them HP prior to their completion of the bowel cancer screening
test kit. Of the 3886 subjects, 2034 subjects (51.4% male, 48.6%
female) were offered HP over the telephone, and 1852 subjects
(47.0% male, 53% female) were offered HP during a group face-to-
face session; 2442 subjects (46.7% male, 53.4% female) of the same
age, who did not receive any intervention, were identified in the
comparison practices in the three boroughs.
‘Invited prevalent 59–60’. Subjects aged between 59 and 60 years
who were invited to the bowel cancer screening programme for the
first time were included in the intervention (Target group 1).
Table 2 shows the overall participation in bowel cancer screening
among the ‘Invited prevalent 59–60’ population group. A total of
913 subjects aged between 59 and 60 years were sent the GP
endorsement letter: 497 subjects were offered HP over the
telephone, and 416 were offered HP during a face-to-face session.
About 1219 subjects of the same age, who did not receive either
intervention, were identified in the comparison practices. The
overall median uptake from April to December 2012 was
significantly higher in both the practices which offered HP over
the telephone (45.7%, MWW P¼ 0.001) and in those which
offered HP at a face-to-face session (41.2%, MWW P¼ 0.02)
compared with the non-intervention practices (34.0%, Table 2).
The median uptake was consistently higher in the intervention
Table 1. Target population: ‘All invited 59–70’ (April to December 2012)
Comparison general practices
Intervention general
practices—telephone
Intervention general
practices—session
Borough
No. of
practices
Males
(%)
Females
(%)
Total
No. of
practices
Males
(%)
Females
(%) Total
No. of
practices
Males
(%)
Females
(%) Total
City & Hackney 5 624 (46.7) 713 (53.3) 1337 3 285 (48.0) 309 (52.0) 594 3 295 (49.0) 307 (51.0) 602
Newham 10 962 (47.0) 1087 (53.0) 2049 3 406 (52.3) 370 (47.7) 776 3 306 (44.7) 379 (55.3) 685
Tower Hamlets 9 856 (46.5) 985 (53.5) 1841 3 355 (53.5) 309 (46.5) 664 3 269 (47.6) 296 (52.4) 565
Total 24 2442 (46.7) 2785 (53.4) 5227 9 1046 (51.4) 988 (48.6) 2034 9 870 (47.0) 982 (53.0) 1852
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practices for each of the three boroughs. Compared with no
intervention, HP over the telephone increased the odds of uptake
in females by 75% (OR¼ 1.75, 95% CI¼ 1.29–2.38, Po0.001) and
by about 60% in males (OR¼ 1.61, 95% CI¼ 1.19–2.17, P¼ 0.002,
Table 3), while HP at face-to-face session increased the odds of
uptake by about 35% in both males and females although this effect
was not significant at the 5% level (Table 3). Being a male overall
reduced the chance of responding to a first invitation by around
25% (OR¼ 0.75, 95% CI¼ 0.59–0.96, P¼ 0.02) but did not impact
on the effect of the interventions (non-significant interaction
terms, data not shown). The odds of uptake did not significantly
differ between the three boroughs (Table 3).
‘Invited prevalent 61–70’. Subjects aged between 61 and 70 years
who had not responded to any of their previous invitations were
also included in the intervention (Target group 2). Table 2 shows
the overall participation in bowel cancer screening among the
‘Invited prevalent 61–70’ population group. A total of 1772 subjects
were sent a GP endorsement letter: 826 subjects were offered
HP over the telephone and 886 subjects were offered HP during a
face-to-face session. About 2316 subjects of the same age, who did
not receive either intervention, were identified in the comparison
practices. The overall median uptake was significantly higher for
both HP interventions (over the telephone: 19.6%, MWW
Po0.001 and face-to-face session: 23.9%, MWW Po0.001)
compared with no intervention (13.0%, Table 2). The odds ratio
between the intervention and the comparison practices were found
to be statistically significantly 41 as shown in Table 3: both types
of intervention increased the odds of uptake by at least 50% in
males (OR¼ 1.59, 95% CI¼ 1.16–2.18, P¼ 0.004 for HP over the
telephone, and OR¼ 2.28, 95% CI¼ 1.69–3.09, Po0.001 for HP at
face-to-face session, both Po0.001) and females (OR¼ 1.78, 95%
CI¼ 1.34–2.37, and OR¼ 1.78, 95% CI¼ 1.36–2.32, respectively,
both Po0.001, Table 3). As observed for the ‘Invited prevalent
61–70’ population, being a male overall reduced the chance of
responding to a first invitation by around 25% (OR¼ 0.77, 95%
CI¼ 0.60–0.99, P¼ 0.04), but did not impact on the effect of either
intervention (non-significant interaction terms, data not shown).
The odds of uptake did not significantly differ between boroughs
(Table 3).
Table 2. Overall participation in bowel cancer screening population groups (April to December 2012)
Comparison general
practices
Intervention general
practices—telephone
Intervention general
practices—session
Borough
Participation
number (screened)/
total number
(invited) overall
practices (%)a
General
practice
median %
uptake (IQR)
Participation
number (screened)/
total number
(invited) overall
practices (%)a
General
practice
median %
uptake (IQR)
Participation
number (screened)/
total number
(invited) overall
practices (%)a
General
practice
median %
uptake (IQR)
‘Invited prevalent 59–60’
City & Hackney 116/334 36.0 (8.3) 74/155 47.6 (12.1) 61/139 43.2 (2.2)
Newham 158/463 34.3 (11.0) 90/188 46.8 (2.6) 60/155 39.7 (4.9)
Tower Hamlets 138/422 33.3 (13.6) 64/154 41.5 (3.5) 50/122 41.2 (15.6)
Total 412/1219 (33.8) 34.0 (11.7) 228/497 (45.9) 45.7 (6.1) 171/416 (41.1) 41.2 (3.6)
‘Invited prevalent 61–70’
City & Hackney 68/532 11.6 (2.3) 43/227 16.7 (2.7) 60/259 19.7 (8.8)
Newham 115/914 13.5 (6.2) 67/303 22.0 (2.9) 81/339 24.8 (2.8)
Tower Hamlets 113/870 13.7 (2.6) 55/296 19.6 (2.5) 62/288 23.9 (4.0)
Total 296/2316 (12.8) 13.0 (4.4) 165/826 (20.0) 19.6 (5.4) 203/886 (22.9) 23.9 (6.1)
‘Invited prevalent 59–70’
City & Hackney 184/866 21.8 (2.0) 117/382 28.1 (5.5) 121/398 28.9 (5.7)
Newham 273/1377 19.2 (3.6) 157/491 33.0 (4.7) 141/494 27.5 (2.4)
Tower Hamlets 251/1292 19.8 (3.7) 119/450 27.1 (3.2) 112/410 25.8 (3.1)
Total 708/3535 (20.0) 20.0 (4.5) 393/1323 (29.7) 28.1 (6.2) 374/1302 (28.7) 27.5 (4.9)
‘Invited incident 61–70’
City & Hackney 376/471 81.8 (6.0) 176/212 82.4 (4.2) 167/204 83.1 (2.4)
Newham 535/669 78.1 (4.5) 231/284 81.5 (0.6) 154/191 79.2 (2.8)
Tower Hamlets 425/546 78.0 (5.2) 173/214 83.1 (4.8) 124/150 70.5 (14.6)
Total 1326/1686 (78.6) 78.3 (5.9) 580/710 (81.7) 81.8 (2.4) 445/545 (81.7) 79.2 (4.8)
‘All invited 59–70’ (target population)
City & Hackney 560/1337 41.0 (7.0) 294/594 48.9 (6.3) 289/602 49.6 (2.9)
Newham 810/2049 38.4 (6.9) 388/776 50.3 (2.9) 295/685 42.6 (0.8)
Tower Hamlets 677/1841 36.5 (3.1) 292/664 45.3 (3.4) 237/565 41.7 (10.1)
Total 2047/5227 (39.2) 39.1 (5.5) 974/2034 (47.9) 46.7 (5.0) 821/1852 (44.3) 43.8 (4.7)
Abbreviation: IQR¼ interquartile Range.
aMean percentage uptake overall practices.
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Table 3. Effect of health promotion intervention type on uptake at general practice level, by gender and London borough in the bowel cancer screening
population groups (ITT analysis—April to December 2012)
Blocked logistic regression output
Explanatory variable Category OR 95% CI Significance (a)
‘Invited prevalent 59–60’
Borough effect City & Hackney 1.00 _ _
Newham 0.95 0.76–1.18 0.6 (0.4)
Tower Hamlets 0.86 0.69–1.08 0.4 (0.07)
Gender effect Female 1.00 _ _
Male 0.75 0.59–0.96 0.02 (0.04)
Intervention effect in femalesb No HP 1.00 _ _
HP over the telephone 1.75 1.29–2.38 o0.001 (o0.001)
HP at face-to-face session 1.37 0.99–1.87 0.06 (0.06)
Intervention effect in malesb No HP 1.00 _ _
HP over the telephonec 1.61 1.19–2.17 0.002 (o0.001)
HP at face-to-face sessionc 1.37 0.98–1.91 0.06 (0.1)
‘Invited prevalent 61–70’
Borough effect City & Hackney 1.00 _ _
Newham 1.06 0.85–1.31 0.6 (0.6)
Tower Hamlets 1.01 0.81–1.27 0.9 (0.4)
Gender effect Female 1.00 _ _
Male 0.77 0.60–0.99 0.04 (0.01)
Intervention effect in femalesb No HP 1.00 _ _
HP over the telephone 1.78 1.34–2.37 o0.001 (o0.001)
HP at face-to-face session 1.78 1.36–2.32 o0.001 (o0.001)
Intervention effect in malesb No HP 1.00 _ _
HP over the telephonec 1.59 1.16–2.18 0.004 (0.002)
HP at face-to-face sessionc 2.28 1.69–3.09 o0.001 (o0.001)
‘Invited prevalent 59–70’
Borough effect City & Hackney 1.00 _ _
Newham 0.95 0.82–1.11 0.5 (0.4)
Tower Hamlets 0.87 0.75–1.02 0.08 (0.1)
Gender effect Female 1.00 _ _
Male 0.82 0.70–0.97 0.02 (0.07)
Intervention effect in femalesb No HP 1.00 _ _
HP over the telephone 1.82 1.49–2.23 o0.001 (o0.001)
HP at face-to-face session 1.51 1.24–1.84 o0.001 (o0.001)
Intervention effect in malesb No HP 1.00 _ _
HP over the telephonec 1.56 1.27–1.93 o0.001 (o0.001)
HP at face-to-face sessionc 1.68 1.36–2.09 o0.001 (o0.001)
‘Invited incident 61–70’
Borough effect City & Hackney 1.00 _ _
Newham 0.98 0.78–1.22 0.8 (0.5)
Tower Hamlets 0.92 0.73–1.16 0.5 (0.4)
Gender effect Female 1.00 _ _
Male 0.87 0.68–1.10 0.2 (0.2)
Intervention effect in femalesd No HP 1.00 _ _
HP over the telephone 1.12 0.82–1.54 0.5 (0.8)
HP at face-to-face session 0.95 0.68–1.32 0.8 (0.4)
Intervention effect in malesd No HP 1.00 _ _
HP over the telephonec 1.21 0.86–1.66 0.3 (0.2)
HP at face-to-face sessione 1.47 1.01–2.15 0.04 (0.2)
‘All invited 59–70’
Borough effect City & Hackney 1.00 _ _
Newham 0.91 0.82–1.01 0.09 (0.04)
Tower Hamlets 0.80 0.72–0.89 o0.001 (o0.001)
Gender effect Female 1.00 _ _
Male 0.83 0.74–0.93 o0.001 (0.002)
Intervention effect in femalesb No HP 1.00 _ _
HP over the telephone 1.49 1.29–1.73 o0.001 (o0.001)
HP at face-to-face session 1.12 0.96–1.29 0.2 (0.2)
Intervention effect in malesb No HP 1.00 _ _
HP over the telephonec 1.39 1.20–1.61 o0.001 (o0.001)
HP at face-to-face sessione 1.36 1.16–1.60 o0.001 (0.006)
Abbreviations: CI¼ confidence interval; HP¼ health promotion; OR¼odds ratio.
aP-values shown after excluding the 12 practices which were included in the pilot (Massat et al, 2014)
bOverall intervention effect (over the telephoneþ face-to-face session) was significant at the 5% level.
cThe effect of intervention (over the telephone/face-to-face session) in males was not significantly different from the effect of intervention in females at the 10% level.
dOverall intervention effect (over the telephoneþ face-to-face session) was not significant at the 5% level.
eThe effect of intervention (over the telephone/face-to-face session) in males was significantly different from the effect of intervention in females at the 10% level.
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‘Invited prevalent 59–70’. The overall results for all those invited
to complete the gFOBt kit for the first time are also presented in
Table 3. They confirm that both interventions had a significant
effect on uptake regardless of gender, borough or practice size, and
there was no significant difference between these two types of
intervention in this patient group (OR¼ 0.94, 95% CI¼ 0.79–1.11,
P¼ 0.5, data not shown).
‘Invited incident 61–70’. The intervention did not intend to
target subjects in this group unless they had not responded to their
most recent gFOBt invitation. During the latter months of the
project, a change in the format of the ITT lists meant that
information about previous participation was not available and
subjects in the group were included in the intervention (see
limitations below). Table 2 shows the overall participation in bowel
cancer screening among the ‘Invited incident 61–70’ population
group. A total of 1255 and 1686 subjects were re-invited for bowel
cancer screening in the intervention practices and the comparison
practices, respectively. Compared with the non-intervention
practices (78.3%, Table 2), the overall median uptake was only
just significantly higher in the practices which offered HP over the
telephone (81.8%, MWW P¼ 0.05) but not in those which offered
HP at a face-to-face session (79.2%, MWW P¼ 0.5). The odds of
uptake did not significantly differ between intervention and
comparison practices (Table 3), although the face-to-face HP
intervention had a significant effect among men (OR¼ 1.47, 95%
CI¼ 1.01–2.15, P¼ 0.04, Table 3) which differed from its effect
among women in this patient group (significant interaction terms,
data not shown). However, this result was not reproduced in the
sensitivity analysis where the 12 practices which received
intervention during the pilot study were excluded from the
analysis dataset (P¼ 0.2, Table 3).
‘All invited 59–70’. When the data from all males and females
routinely invited for gFOBt screening during April to December
2012 was analysed (see Table 1 for details), the median uptake in
each borough was still observed to be consistently higher in the
intervention practices than in the comparison practices (Table 2,
HP over the telephone 46.7%, MWW Po0.001, HP at a face-to-
face session 43.8%, MWW P¼ 0.01). The effect of the over the
telephone HP intervention on the odds of uptake was still found
to be highly significant for both females (OR¼ 1.49, 95%
CI¼ 1.29–1.73, Po0.001) and males (OR¼ 1.39, 95% CI¼ 1.20–
1.61, Po0.001, Table 3), whereas the effect of the face-to-face
session HP intervention only remained significant among men
(OR¼ 1.36, 95% CI¼ 1.16–1.60, Po0.001, Table 3). As expected
from the results obtained for individual patient groups, the odds of
uptake were overall significantly lower, around 15% lower, in men
compared with women in the absence of any intervention
(OR¼ 0.83, 95% CI¼ 0.74–0.93, Po0.001, Table 3). In addition,
the odds of uptake were highest in City and Hackney (Table 3).
The results described above remained largely unchanged when
the 12 GP practices which had been involved in the 2011 pilot
phase of the study were excluded from the analysis (see Table 3 for
details).
DISCUSSION
Bowel cancer screening participation has been observed to be lower
in deprived groups and in certain ethnic groups, notably South
Asian since the inception of the programme in the UK (Whynes
et al, 2003; von Wagner et al, 2009; Moss et al, 2012; Mansouri
et al, 2013).
Our results show that a population-level health promotion
package delivered around the time of receipt of a patient’s first
gFOBt kit substantially and significantly improved uptake in an
ethnically-diverse and relatively deprived population with low
awareness and participation. In the prevalent population group
aged 59–60, uptake increased from 34 to 44%, whereas in the
prevalent population group aged 61–70, uptake increased from 13
to 21.5% (both interventions included). In contrast, little change
was observed in the incident population group; this was expected
as the baseline uptake was already very high (78.3%).
The results suggest that offering health promotion over the
telephone was overall the most effective intervention of the two
approaches in providing information and in increasing uptake at
population level (although the difference was not significantly
different from the effect of offering face-to-face health promotion
in group sessions, data not shown). Face-to-face health promotion
sessions may have more impact on men in terms of making the
decision to return the gFOBt kit. This could be the result of a direct
interaction between this type of intervention and male-specific
behaviours (Christy et al, 2014) or a consequence of the social
behaviour of Pakistani and Bangladeshi women (Ahmed and Dale,
2008). Other authors only reported a positive association
between attendance at a public information talk and uptake of
colorectal screening among women of south east Asian ethnicity
(Singaporean population, Wong et al, 2013).
The NHS BCSP aims to offer informed choice to eligible
subjects. In areas of high ethnic diversity and socio-economic
deprivation, where English language skills, health literacy and
awareness of cancer screening programmes are lower than average,
‘informed’ choice is more difficult to achieve. This intervention
aimed to reduce the inequalities in access to information by
offering verbal information and discussion in the subjects’ first
language, while avoiding potential coercion. Trained bi-lingual
advocates working with GP practices used standardised health
promotion scripts, ensuring that subjects contacted could opt out
of the intervention at any point and that they understood that they
were not required to participate in bowel cancer screening. Records
of telephone conversations and follow-up calls confirmed that
some subjects made an informed choice not to participate in the
screening.
The study was carried out in a real-life environment and a
number of variables were outside the control of the researchers,
making it difficult to adhere to the protocol throughout the project
and leading to some degree of imprecision in the population
groups studied. However, similar challenges might be expected if
the intervention were to be repeated in comparable populations. A
number of observations arose in relation to the delivery of the
planned interventions.
(1) Currently, GPs do not have access to information about
individuals who are due to be invited to participate in screening.
Only individuals approaching the age of 60 and due for their first
invitation can be identified through practice registers. A change in
policy by the NHS BCSP enabling GPs to receive lists of invited
people ahead of their screening invitation would be required for
wider adoption of this intervention.
(2) During the 9 months of the intervention period, uptake data
showed that 13.5% more subjects had been invited to participate in
the NHS BCSP than appeared on the ITT lists sent to the
intervention GP practices, suggesting that not all invited subjects
received the intervention.
(3) Incorrect telephone numbers contributed to callers being
unable to make contact with 48% of subjects in the HP over the
telephone group and 45% in the HP face-to-face group. This meant
that only just over half the target population received the full
intervention. Related to this, some address data is likely to have
been out of date so that some targeted people may have received
neither the invitation nor the intervention. Routine updating of
patient details on practice registrars could potentially increase the
impact of the intervention.
(4) Part way through the project, reduced capacity in the NHS
BCSP led to an extended delay in providing ITT lists. When these
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resumed, the format had changed and information about previous
invitations and opt-out status were omitted. Thus during the last 4
months of the project, the intervention may not have coincided
with the gFOBt invitation, and was offered to all invited subjects,
regardless of previous participation or opt-out status. In a wider
programme, resources in the NHS BCSCP would need to be
ensured to enable consistent information to be available to GPs.
(5) Finally, incomplete or inaccurate NHS BCSP records meant
that subjects with a diagnosis of colorectal cancer were not always
identified from GP records, and callers needed to be aware that the
intervention may have been applied inappropriately.
Improvements in any of these areas would likely lead to a more
effective intervention.
There are other aspects of adherence in the screening ‘journey’
which would merit future research. Returning the gFOBt kit is the
first stage in participation to the NHS BCSP, full benefit being
obtained when individuals who test positive progress to further
investigation (usually colonoscopy). Uptake of colonoscopy has
been shown to be lower in more deprived and in non-White
populations (Morris et al, 2012b). An informal audit by the NHS
BCSP of people tested in 2012 indicates high rates of withdrawal
from the programme before colonoscopy in inner NEL. A high
proportion of these appear to be individuals with one or more
normal results during previous screening episodes and who had
attended for assessment at a specialist practitioner clinic. There is
no information on subsequent pathways for this group. Further
research is indicated into reasons for withdrawal from the
programme (at various stages) by people identified at very high
risk of bowel cancer through screening.
To comply with confidentiality regulations according to the
service level agreements already in place, the study did not seek to
track individual results. In addition, it was not possible to identify
whether an individual who had received telephone or face-to-face
health promotion had returned a completed gFOBt kit. Therefore,
only aggregate practice-level data was analysed by comparing
uptake rates for the practices chosen at random to receive the
interventions with uptake rates in the comparison (non-interven-
tion) practices. However, uptake rates are based on official number
of gFOBt kits sent out from and returned to the bowel screening
hubs. Thus, we analysed official data from the screening
programme, with the consequent standards of data quality and
accuracy.
Future analyses will investigate the effects of practice attributes,
including size, training status and ethnic breakdown.
Delivery costs included staffing (bi-lingual advocates), training,
information resources and disposable gloves, stationary, postage
and telephone calls and follow-up interviews. The total budget was
d50 000, equivalent to d10 per planned/ITT person targeted. If
provided as part of routine primary care by GP practices, we
estimate costs at d6 per head; management costs for an external
commissioned organisation and follow-up interviews would not be
required. These costs are consistent with those estimated for a
similar intervention used as part of distributional cost-effectiveness
analysis of the NHS BCSP: d7 per person targeted with an
estimated increase in mean gFOBt uptake of 12% (Asaria et al,
2013). The analysis suggested that such a targeted screening
strategy was cost effective and may contribute to a reduction in the
health inequalities accompanying the implementation of a
universal screening programme.
Endorsement of GP has been observed, both in the UK and
elsewhere, to be effective in increasing FOBt uptake (Cole et al,
2002; Hewitson et al, 2011). Advance notification letter prior to the
standard invitation-to-screen letter has also been shown to
improve participation (Cole et al, 2007; Libby et al, 2011), while
automated telephone calls providing a description of and health
benefits of gFOBt have been found to significantly improve uptake
rates in a US trial (Mosen et al, 2010). A trial is currently
evaluating the effectiveness of a GP-endorsed reminder in
improving patient participation in the NHS BCSP in the West
Midlands (Damery et al, 2012), while the efficacy of a patient
decision aid (fridge magnet with telephone help line and website)
distributed by community-based family physicians is being
evaluated in a Canadian trial (Clouston et al, 2012). None of
these interventions are focussed specifically on Asian or ethnically-
diverse populations. To our knowledge, this study is the first to
demonstrate experimentally that a telephone promotion improves
participation. The findings suggest that telephone information and
promotion may directly engage more subjects invited to participate
in the NHS BCSP for the first time than offering face-to-face health
promotion, may have a greater impact on increasing bowel cancer
screening uptake and therefore in reducing health inequalities, and
is likely to be more cost-effective.
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